Last reviewed · How we verify
Amiodarone in Parenteral Dosage Form — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Amiodarone in Parenteral Dosage Form (Amiodarone in Parenteral Dosage Form) — Our Lady of the Lake Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Amiodarone in Parenteral Dosage Form TARGET | Amiodarone in Parenteral Dosage Form | Our Lady of the Lake Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Amiodarone in Parenteral Dosage Form CI watch — RSS
- Amiodarone in Parenteral Dosage Form CI watch — Atom
- Amiodarone in Parenteral Dosage Form CI watch — JSON
- Amiodarone in Parenteral Dosage Form alone — RSS
Cite this brief
Drug Landscape (2026). Amiodarone in Parenteral Dosage Form — Competitive Intelligence Brief. https://druglandscape.com/ci/amiodarone-in-parenteral-dosage-form. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab